Moleculin Biotech MBRX
-
-
-
已收盤:-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q3 | 10.01 | 113.42 | 20.62 | -6,611 | -6 | |
| 2026Q2 | 55.8 | 99.59 | -21.2 | -7,561 | -8 | |
| 2026Q1 | 45.8 | 61.3 | -70.8 | -7,874 | -13 | |
| 2025Q4 | 66.2 | -54.53 | 610.63 | -7,533 | 16 | |
| 2025Q3 | 265 | 23.31 | -226.83 | -5,907 | -25 | |
| 2025Q2 | 150.95 | 70 | -636.2 | -5,720 | -8 | |
| 2025Q1 | 486.8 | 92.34 | -316 | -5,943 | -6 | |
| 2024Q4 | 850 | 288.95 | -437.8 | -6,643 | -2 | |
| 2024Q3 | 1420 | 67.37 | -1490 | -7,136 | -11 | |
| 2024Q2 | 1760 | 143.2 | -845 | -6,185 | -4 | |
| 2024Q1 | 2955 | 134.35 | -1010 | -6,677 | -5 | |
| 2023Q4 | 6438 | 86.85 | -2565 | -8,919 | -10 | |
| 2023Q3 | 3206.25 | 106.01 | -1405 | -5,946 | -6 | |
| 2023Q2 | 4341 | 107.3 | -1500 | -6,412 | -6 | |
| 2023Q1 | 7200 | 105.55 | -2065 | -8,354 | -8 | |
| 2022Q4 | 7950 | 104.11 | -1760.29 | -7,048 | -7 | |
| 2022Q3 | 7950 | 105.5 | -2249.89 | -9,085 | -9 | |
| 2022Q2 | 10875 | 109.68 | -1799.91 | -7,433 | -7 | |
| 2022Q1 | 13350 | 103.01 | -1799.91 | -7,074 | -7 | |
| 2021Q4 | 13950 | 184.25 | -674.97 | -5,205 | -3 |